JohnGibbsMDMHCM, FACS

PubMed

• 8 citations
  Social determinants of health associated with poor outcome for rural patients following resected pancreatic cancer
  Quyen D. Chu, Mei-Chin Hsieh, John F. Gibbs, Xiao-Cheng Wu
  Journal of Gastrointestinal Oncology. 2021-01-01
• 132 citations
  Epithelial-mesenchymal transition (EMT) and activated extracellular signal-regulated kinase (p-Erk) in surgically resected pancreatic cancer.
  Milind Javle, John F. Gibbs, K. K. Iwata, Youngju Pak, P. Rutledge
  Annals of Surgical Oncology. 2007-09-19
• 18 citations
  Renal Atrophy Secondary to Chemoradiotherapy of Abdominal Malignancies
  Gary Y. Yang, Kilian Salerno May, Renuka Iyer, Rameela Chandrasekhar, Gregory E. Wilding
  International Journal of Radiation Oncology, Biology, Physics. 2010-10-01

Journal Articles

• Appropriateness of Systemic Treatments in Unresectable Metastatic Well-differentiated Pancreatic Neuroendocrine Tumors  
  Strosberg JR, Fisher GA, Benson AB, Anthony LB, Arslan B, Gibbs JF, Greeno E, Iyer RV, Kim MK, Maples WJ, Philip PA, Wolin EM, Cherepanov D, Border MS., World Journal of Gastroenterology, 1/1/2015
• The Dormant Virus: A Rare Case of Herpes Simplex Virus (HSV) Hemorrhagic Necrotizing Enterocolitis  
  Vabi BW, Singh R, Gibbs JF, Paterson J, Merchant S, The American Surgeon, 1/1/2015
• Tumor Priming by Apo2L/TRAIL Reduces Interstitial Fluid Pressure and Enhances Efficacy of Liposomal Gemcitabine in a Patient Derived Xenograft Tumor Model  
  Hylander BL, Sen A, Beachy SH, Pitoniak R, Ullas S, Gibbs JF, Qui J, Prey JD, Fetterly GJ, Repasky E, Journal of Controlled Release, 1/1/2015
• Influence of the Implantation Site on the Sensitivity of Pancreatic Tumor Xenografts to Apo2L/TRAIL Therapy  
  Sharma R, Buitrago S, Pitoniak R, Gibbs JF, Curtin L, Seshadri M, Repasky EA, Hylander BL, Pancreas, 1/1/2014
• Systemic Treatment in Unresectable Metastatic Well-differentiated Carcinoid Tumors: Consensus Results a Modified Delphi Process  
  Stosberg JR, Fisher G, Benson AB, Malin JL, Anthony L, Arslan B, Gibbs JF, Greeno E, Iyer R, Kim MK, Maples W, Philip PA, Wolin E, Cherepanov D, Broder MS, Pancreas, 1/1/2013
• Evaluation of Phosphatidyl Inositol 3-kinase Catalytic Subunit (PIK3CA) And Epidermal Growth Factor Receptor (EGFR) Gene Mutations in Pancreaticobiliary Adenocarcinoma  
  Weiss GA, Rossi M, Khushalani N, Lo K, Gibbs JF, Bharthuar A, Cowell J, Iyer R, Journal of Gastrointestinal Oncology, 1/1/2013
• Change in CA 19-9 Levels after Chemoradiotherapy Predicts Survival in Patients with Locally Advanced Unresectable Pancreatic Cancer  
  Yang GY, Malik NK, Chandrasekhar R, Ma WW, Flahery L, Iyer R, Kuvshinoff B, Gibbs J, Wilding G, Warren G, May KS, Journal of Gastrointestinal Oncology, 1/1/2013
• MLN2238, a Proteasome Inhibitor, Induces Caspase-dependent Cell Death, Cell Cycle Cycle Arrest, and Potentiates the Cytotoxic Activity of Chemotherapy Agents in Rituxi...  
  Gu JJ, Hernandez-Ilizliturri FJ, Mavis C, Czuczman NM, Deeb G, Gibbs J, Skitzki JJ, Patil R, Czuczman MS, Anticancer Drugs, 1/1/2013
• Ofatumuab Demonstrates Activity against Rituximab-sensitive and -resistant Cell Lines, Lymphoma Xenografts and Primary Tumour Cells from Patients with B-cell Lymphoma  
  Barth MJ, Hernandez-Llizaliturri FJ, Mavis C, Tsai PC, Gibbs JF, Deeb G, Czuczman MS, British Journal of Haematology, 1/1/2012
• Treatment of Locally Advanced Unresectable Pancreatic Cancer: A 10-year Experience  
  Malik NK, May KS, Chandrasekhar R, Ma WW, Flaherty L, Iyer R, Gibbs J, Kuvshinoff B, Wilding G, Yang GY, Journal of Gastrointestinal Oncology, 1/1/2012
• Patient Surveillance after Treatment for Soft-tissue Sarcoma  
  Johnson FE, Sakata K, Sarkar S, Audisio RA, Kraybill WG, Gibbs JF, Beitler AL, Virgo, International Journal of Oncology, 1/1/2011
• Distinct Cellular and Therapeutic Effects of Obatoclax in Rituximab-sensitive and -resistant Lymphomas  
  Brem EA, Thudium K, Khubchandani S, Tsai PC, Olejniczak SH, , Bhat S, Raiz W, Gu J, Iqbal A, Campagna R, Knight J, Mavis C, Hoskin P, Deeb G, Gibbs JF, Czuczman MS, He..., British Journal of Haematology, 1/1/2011
• Analysis of Clinical and Dosimetric Factors Associated with Change in Renal Function in Patients with Gastrointestinal Malignancies after Chemoradiation to the Abdomen  
  May KS, Khushalani NI, Chandreasekhar R, Wilding G, Iyer R, Ma WW, Flaherty L, Russo RC, Fakih M, Kuvshinoff BW, Gibbs JF, Javle MM, Yang GY, International Journal of Radiation Oncology Biology Physics, 1/1/2010
• Renal Atrophy Secondary to Chemoradiotherapy of Abdominal Malignancies  
  Yang GY, May KS, Iyer R, Chandreasekhar R, Wilding G, McCloskey SA, Khushalani NI, Yendamuri SS, Gibbs JF, Fakih M, Thomas CR, International Journal of Radiation Oncology Biology Physics, 1/1/2010
• Recent Advances in the Management of Primary Hepatic Tumors, Refinement of Surgical Techniques, and Effect on Outcome  
  Sharma R, Gibbs JF., Journal of Surgical Oncology, 1/1/2010
• Regional Treatment of Colorectal Liver Metastases  
  Kulaylat MN, Gibbs JF, Journal of Surgical Oncology, 1/1/2010
• Thermoablation of Colorectal Liver Metastases  
  Kulaylat MN, Gibbs JF, Journal of Surgical Oncology, 1/1/2010
• Association of Technetium99m MAG-3 Renal Scintigraphy with Change in Creatinine Clearance following Chemoradiation to the Abdomen in Patients with Gastrointestinal Mal...  
  May KS, Yang GY, Khushalani NI, Chandreasekhar R, Wilding GE, Flaherty L, Malhotra HK, Russo RC, Warner JC, Yap JC, Iyer RV, Nwogu CE, Yendamuri SS, Gibbs JF, Nava HR,..., Journal of Gastrointestinal Oncology, 1/1/2010
• Distinct Molecular Mechanisms Responsible for Bortezomib-induced Death of Therapy -resistant versus -sensitive B-NHL Cells  
  Olejniczak SH, Blickwedehl J, Belicha-Villanueva A, Bangia N, Riaz W, Mavis C, Clements JL, Gibbs J, Hernandez-Ilizaliturri FJ, Czuczman MS, Blood, 1/1/2010
• Neuroendocrine Tumors  
  Clark OH, Ajani JA, Benson AB 3rd, Berlin JD, Blaszkowsky LS, Byrd D, Choti MA, Doherty GM, Engstrom PF, Gibbs JF, Heslin MJ, Kandeel F, Kessinger A, Kulke MH, Kunz P,..., Journal of the National Comprehensive Cancer Network, 1/1/2009
• NCCN Clinical Practice Guidelines in Oncology: Hepatobiliary Cancers  
  Benson AB 3rd, Abrams TA, Ben-Josef E, Bloomston PM, Botha JF, Clary BM, Covey A, Curley SA, D'Angelica MI, Davila R, Ensminger WD, Gibbs JF, Laheru D, Malafa MP, Marr..., Journal of the National Comprehensive Cancer Network, 1/1/2009
• Bevacizumab Combined with Gemcitabine and Capecitabine in Advanced Pancreatic Cancer: A Phase II Study  
  Javle M, Yu J, Garrett C, Pande A, Kuvshinoff B, Litwin AM, Phelan J 3rd, Gibbs J, Iyer R, British Journal of Cancer, 1/1/2009
• Co-expression of Urokinase with Haptoglobin in Human Carcinomas  
  Harvey S, Kohga S, Sait SNJ, Markus G, Hurd TC, Martinick M, Geradts J, Saxena R, Gibbs JF., Journal of Surgical Research, 1/1/2009
• Surgical Resection after TNFerade Therapy for Locally Advanced Pancreatic Cancer  
  Chadha MK, Litwin A, Levea C, Yang G, Javle MM, Gibbs JF, Journal of the Pancreas, 1/1/2009
• Effective Endovascular Stenting for Portal Vein Occlusion following Pancreaticoduodenectomy  
  Ellis CM, Schlolein S, Shenoy S, Litwin A, Gibbs JF, HPB Surgery, 1/1/2009
• Join now to see all

Books/Book Chapters

• Surgical Oncology-A Practical and Comprehensive Approach 
  Chapter: Cho E, Gibbs JF, Rodriguez-Bigas M, Rodrigues LM 
  Cho E, Gibbs JF, Rodriguez-Bigas M, Rodrigues LMEditors: Chu Q, Gibbs JF, Zabari G.Springer2014
• Surgical Oncology-A Practical and Comprehensive Approach 
  Chapter: Small Bowel Cancer 
  Gleason D, Miller K, Gibbs JFEditors: Chu Q, Gibbs JF, Zabari G.Springer2014
• Surgical Oncology-A Practical and Comprehensive Approach 
  Chapter: Cholangiocarcinoma 
  Mafi P, Chu QD, Smith R, Gibbs JFEditors: Chu Q, Gibbs JF, Zabari G.Springer2014
• Surgical Oncology-A Practical and Comprehensive Approach 
  Editors: Chu Q, Gibbs JF, Zabari G.2014
• Gastrostomy 
  Chapter: Defining the Indications for Prophylactic Percutaneous Endoscopic Gastrostomy Tubes in Head and Neck Cancer Patients 
  Page 73 - 80Foster JM, Filacoma P, Brady B, Loree T, Gibbs JFEditors: Kohout P.Croatia, Tech, Rijeka2011
• Biliary Tract and Gall Bladder Neoplasms 
  Chapter: Overview of Emerging Strategies in the Management of Intrahepatic Cholangiocarcinoma 
  Page 181 - 194Smith RR, Gibbs JFEditors: Thomas CR, Fuller CD.Demos Publishing2008
• Gastrointestinal Cancers: A Companion to Sleisenger and Fordtran's Gastrointestinal and Liver Disease 
  Chapter: Surgery of Pancreatic Carcinoma 
  Page 541 - 547Gibbs JF, Smith JL, Douglass HOEditors: Rustgi AK, Crawford J.WB Saunders Publishers2003
• Encyclopedia of Cancer 
  Chapter: Pancreas and Periampullary Tumors 
  Page 369 - 381Douglass HO, Smith JL, Nava HR, Gibbs JFEditors: Bertino JR.Elsevier Science (USA), San DiegoEdition 2nd,2002
• Principles and Practice of Palliative Care and Supportive Oncology 
  Chapter: Palliative Surgery 
  Page 710 - 721Whooley BP, Milch RA, Gibbs JFEditors: AM Berger, RK Portenoy, DE Weissman.Lippincott, Williams, and Wilkins, Philadelphia, PAEdition 2nd,2002
• Chassin's Operative Strategy in General Surgery 
  Chapter: Concepts in Lymphadenectomy 
  Page 863 - 868Edge SB, Gibbs JFEditors: C Scott-Conner.Springer-Verlag, New York, New York2001
• Surgical Oncology: Yesterday, Today, and Tomorrow. An Annotated Bibliography of Important Literature on Common Problems in Surgical Oncology 
  Chapter: Hepatobiliary 
  Gibbs JFEditors: SB Edge, PP Pisters.The Society of Surgical OncologyEdition 2nd,2001
• Surgical Oncology: Yesterday, Today, and Tomorrow 
  Chapter: An Annotated Bibliography of Important Literature on Common Problems in Surgical Oncology 
  Gibbs JF. HepatobiliaryEditors: SB Edge, PP Pisters.The Society of Surgical OncologyEdition 1st,2000
• Join now to see all

Abstracts/Posters

• Change in Renal Function after Chemoradiotherapy for Pancreatic Cancer
  Salerno May K, Chandrasekhar R, Flaherty L, Russo RC, MA WW, Kuvshinoff BW, Gibbs JF, Wilding GE, Yang G, GI ASCO, 1/1/2010
• Characterization of CD8+ T Cells Activated by Intact Urokinase-type Plasminogen Activator Receptor (uPAR) Bone Marrow Derived Dendritic Cells (BMDC's).
  Yu N, Gibbs JF, Shrikant P., Residency Scholarly Exchange Day, State University of New York at Buffalo, 1/1/2008
• How Is Cancer Information Disseminated outside of a Formal Community Based Cancer Education Program?
  Hurd T, Sunil T, Seguin-Mika V, Gibbs J., American Association of Cancer Education, 1/11/2007
• Multicenter, Open-label, Phase II Study of Gemcitabine, Capecitabine, and Bevacizumab (Avastin(R)) In Pancreatic Cancer.
  Gibbs JF, GI ASCO, 1/1/2006
• Expression of a Truncated Urokinase (UK) In Disulfide Complex with Haptoglobin (Hp) And a Neural Cell Adhesion-like Molecule (NCAM) In Human Carcinomas
  Gibbs JF, 3rd International NCI-EORTC Meeting on Cancer Molecular Markers from Discovery to Clinical Practice, Brussels, Belgium, 1/18/2004
• Urokinase Type Plasminogen Activator (u-PA) Is a Predictor of Malignancy in Cytologic Brushings Obtained at Endoscopic Retrograde Cholangiopancreatography
  Gibbs JF, Digestive Disease Week, New Orleans, LA, 1/1/2004
• Safety and Efficacy of TNFerade in Unresectable Locally Advanced Pancreatic Cancer: Results of a Dose Escalating Study
  Gibbs JF, 9th World Congress on Advances in Oncology, Crete Greece, 1/1/2004
• Preoperative Endoscopic Ultrasound Staging Inaccurately Predicts Postoperative Tumor Depth for Esophageal Carcinoma
  Gibbs JF, SAGES, 1/1/2003
• Lymph Node Ratio More Accurately Predicts Outcome following Resection of Esophageal Carcinoma
  Gibbs JF, American Society of Clinical Oncology, 1/1/2003
• Evolution of Sentinel Lymph Node Biopsy for Melanoma at an NCI Approved Cancer Center
  Sabel MS, Gibbs J, McKinley B, Cheney R, Kraybill WG, Sentinel Node 2000, 2nd International Sentinel Node Congress, 1/1/2000
• Activity of NC-190, A Novel Benzophenazine Topoisomerase II Inhibitor
  Gibbs JF, Against Sensitive and Drug-Resistant Breast Cancer, San Antonio, TX, 1/1/1996
• Regulation of Doxorubicin-Induced DNA Damage between Sensitive and Drug-resistant Cancer Cell Lines
  Gibbs JF, Society of Surgical Oncology, Atlanta, GA, 1/1/1996
• In Vitro Activity of a Novel Chemotherapeutic Agent, N-beta-dimethylaminoethyl -9-carboxy -5-hydroxy -10- Methoxybenzo [A] Phenazine-6-carboxamide (NC-190) Against Hum...
  Gibbs JF, American Association for Cancer Research, San Francisco, CA, 1/1/1994
• Role of Drug Concentration in Adriamycin-induced Apoptosis and Necrosis
  Gibbs JF, American Society of Clinical Oncologists, Dallas TX, 1/1/1994
• New Parameters in Aberrant Crypt Foci Evaluation in Colon Carcinogenesis (Glutathione S-Transferase, B-RAF Mutation, Genomic Instability, Single Nucleotide Polymorphis...
  Gibbs JF, GI ASCO
• Join now to see all

Lectures

• Melanoma and Skin Cancer: What's the Sun Have to Do with Me? 
  1/30/2015
• Immunotherapy and Targeted Therapy for Unresectable or Advanced Malignant Melanoma 
  Bayshore Community Hospital - 1/24/2015
• Keynote Speaker: The Foregut Problem- A Translation Dilemma 
  San Juan, PR - 1/18/2015
• Gastrointestinal Stromal Tumors: The journey of CD117 and TKI's 
  Jersey Shore University Medical Center - 1/16/2015
• Update on the Current Management Management of Malignant Melanoma 
  1/7/2015
• The Need for Oncology-specific Variables in Publically Reported Centralized Databases 
  1/4/2015
• Malignant Melanoma: Prevention, Recognition, and Management 
  1/4/2015
• Pancreatic Cancer: Current and Expanding Criteria for Resection 
  South Buffalo Mercy Hospital - 1/28/2014
• Immunotherapy and Targeted Therapy for Malignant Melanoma 
  Jersey Shore University Medical Center/Meridian Health - 1/21/2014
• Pancreatic Cancer: A Diagnostic and Therapeutic Overview 
  Sister's Hospital - 1/20/2014
• Paclitaxel Augments Vaccination Induced CD8+ Tcell Responses 
  1/1/2013
• Rapamycin Augments Dendritic Cell Mediated Tumor Immunity 
  1/1/2013
• Colorectal Liver Metastases: "We've Come a Long Way Baby". 
  SUNY at Buffalo - 1/20/2012
• Therapeutic Targets in Pancreatic Cancer: From TRAIL to uPA 
  Roswell Park Cancer Institute - 1/19/2010
• Therapeutic Obstacles in Pancreatic Cancer: From TRAIL to uPA 
  Loyola University - 1/17/2010
• Therapeutic Obstacles in Pancreatic Cancer: The Challenge for Future Scientists 
  Roswell Park Cancer Institute - 1/13/2010
• Damage Control: Managing Extremely Difficult Intra-operative Scenarios in Surgical Oncology 
  St. Louis, MO - 1/6/2010
• Apo2L/TRAIL Inhibits Growth of Patient Pancreatic Tumors in an Orthotopic, Metastasizing Xenograft SCID Mouse Model 
  1/1/2010
• Activity of Ofatumumab, a Fully Human Monoclonal Antibody (MAb) Targeting CD20, against Rituximab-sensitive Cell Lines (RSCL), Rituximab-resistant Cell Lines (RRCL), L... 
  1/1/2010
• Apo2L/TRAIL Reduces Interstitial Fluid Pressure and Enhances Gemcitabine Update in Patient Pancreatic Tumor Xenografts 
  1/1/2010
• Change of CA 19-9 after Chemoradiotherapy Predicts Survival in Patients with Locally Advanced Unresectable Pancreatic Cancer 
  1/1/2010
• Hepatobiliary Pathophysiology and the Workup of the Liver Mass 
  SUNY, Department of Surgery - 1/26/2009
• Viral Oncogenesis in Hepatocellular Carcinoma 
  LSU Health Sciences Center-Shreveport LA - 1/17/2009
• Update on Current Management of Colorectal Liver Metastases 
  WCA Hospital, Jamestown NY - 1/16/2009
• Pancreatic Cancer: What Is Our Current Understanding of Tumor Biology with Future Therapeutic Implications 
  Roswell Park Cancer Institute - 1/2/2009
• Join now to see all

Other

• The Role of the Commission on Cancer, Cancer Liaison Physician, Web Conference 
  
  1/8/2005
• Highlights of Changes to the TNM Staging: AJCC Cancer Staging Manual, 6th Edition 
  Clifton Springs
  1/30/2003